Navigating the Risks of GLP-1 Medications After Bariatric Surgery
June 5, 2024 · 0 commentsEditor's note: "Navigating the Risks of GLP-1 Medications After Bariatric Surgery" by Patricia Hill is part one of a three-part series. Recently, the use of GLP-1 receptor agonists, like Wegovy, Mounjaro, Ozempic, and Zepbound, has gained popularity as an effective treatment for weight management and type 2 diabetes. We already